Objectives: Studies on atherothrombosis, a major cause of cardiovascularevents, are hampered by the lack of animal models spontaneously developingatherothrombosis. Major underlying problems are the stability ofthe atherosclerotic plaques, combined with the strong plasma anticoagulantactivity. We hypothesized that inhibition of the anticoagulant systemby silencing of protein C (Proc) may cause murine atherosclerotic plaquesto become prone to atherothrombosis.Biopharmaceutic
OBJECTIVE: Human C-reactive protein (CRP) was reported to accelerate atherosclerotic lesion developm...
Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective proper...
Ischaemic stroke is caused by occlusive thrombi in the cerebral vasculature. Although tis-sue-plasmi...
Murine atherosclerosis models do not spontaneously develop atherothrombotic complications. We invest...
Murine atherosclerosis models are key for investigation of atherosclerosis pathophysiology and drug ...
Silencing of anticoagulant protein C using RNA interference (siProc) evokes low incident but spontan...
BACKGROUND: Variations in the blood coagulation activity, determined genetically or by medication, m...
Background: Variations in the blood coagulation activity, determined genetically or by medication, m...
Atherothrombotic events such as myocardial infarction and ischemic stroke are a major cause of morbi...
Activated protein C (APC) is a potent physiologic anticoag-ulant with profibrinolytic properties, an...
During my research project we mainly focussed on studying the pathophysiology of venous and arterial...
Blood clots can form in response to an injury to stop potentially dangerous bleeding. However, a num...
<div><p>Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotectiv...
Thrombin has been proposed to play a key role in the development of atherosclerosis, both by promoti...
OBJECTIVE: Human C-reactive protein (CRP) was reported to accelerate atherosclerotic lesion developm...
Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective proper...
Ischaemic stroke is caused by occlusive thrombi in the cerebral vasculature. Although tis-sue-plasmi...
Murine atherosclerosis models do not spontaneously develop atherothrombotic complications. We invest...
Murine atherosclerosis models are key for investigation of atherosclerosis pathophysiology and drug ...
Silencing of anticoagulant protein C using RNA interference (siProc) evokes low incident but spontan...
BACKGROUND: Variations in the blood coagulation activity, determined genetically or by medication, m...
Background: Variations in the blood coagulation activity, determined genetically or by medication, m...
Atherothrombotic events such as myocardial infarction and ischemic stroke are a major cause of morbi...
Activated protein C (APC) is a potent physiologic anticoag-ulant with profibrinolytic properties, an...
During my research project we mainly focussed on studying the pathophysiology of venous and arterial...
Blood clots can form in response to an injury to stop potentially dangerous bleeding. However, a num...
<div><p>Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotectiv...
Thrombin has been proposed to play a key role in the development of atherosclerosis, both by promoti...
OBJECTIVE: Human C-reactive protein (CRP) was reported to accelerate atherosclerotic lesion developm...
Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective proper...
Ischaemic stroke is caused by occlusive thrombi in the cerebral vasculature. Although tis-sue-plasmi...